Published in Am J Med on July 01, 1998
Cutaneous malakoplakia: case report and review. An Bras Dermatol (2013) 0.86
Multiple chemical sensitivity and idiopathic environmental intolerance (part one). Environ Health Prev Med (2003) 0.79
Gallbladder malakoplakia in type 2 diabetes mellitus: a rare entity. BMJ Case Rep (2012) 0.75
Enteral Malakoplakia Prior to Helicobacter cinaedi Bacteremia. Am J Gastroenterol (2017) 0.75
Malakoplakia of the kidney extending to the descending colon in a patient with secondary adrenal insufficiency: a case report. Korean J Fam Med (2011) 0.75
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73
Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet (2001) 6.82
The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med (1989) 5.02
Dimensional assessment of chronic fatigue syndrome. J Psychosom Res (1994) 4.35
Hereditary periodic fever. N Engl J Med (2001) 4.05
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet (1999) 3.44
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis (1990) 3.20
Adverse reactions to co-trimoxazole in HIV infection. Lancet (1991) 3.16
General primer-mediated PCR for detection of Aspergillus species. J Clin Microbiol (1994) 2.81
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med (2000) 2.70
Rapid, polymerase chain reaction-based identification assays for Candida species. J Clin Microbiol (1993) 2.70
Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol (2001) 2.53
Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol (1997) 2.53
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38
Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis (2001) 2.35
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol (2007) 2.29
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species. Clin Infect Dis (1993) 2.13
[Postanginal sepsis caused by Fusobacterium necrophorum: Lemierre syndrome]. Ned Tijdschr Geneeskd (1993) 2.11
The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol (1996) 2.09
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect (2014) 2.06
[Measurement of the body temperature of adults by rectal digital thermometer and the infrared tympanic thermometer: equally good results in the department of internal medicine]. Ned Tijdschr Geneeskd (1997) 2.04
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy (2013) 2.03
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest (1996) 2.03
Invasive aspergillosis caused by Aspergillus ustus: case report and review. J Clin Microbiol (1999) 2.02
[Chronic fatigue syndrome. I. Somatological hypothesis]. Ned Tijdschr Geneeskd (1991) 2.01
Catheter-related epidural abscesses -- don't wait for neurological deficits. Acta Anaesthesiol Scand (2002) 1.98
[Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation]. Ned Tijdschr Geneeskd (1998) 1.98
[Belt and suspenders. Medical jargon in The Netherlands and Flanders]. Ned Tijdschr Geneeskd (1994) 1.97
Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol (1995) 1.96
Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol (1988) 1.93
Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol (1995) 1.89
Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis (1995) 1.88
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum (1993) 1.79
Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet (1996) 1.78
Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology (1986) 1.78
Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) (1994) 1.78
Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol (2000) 1.76
Comparative study of seven commercial yeast identification systems. J Clin Pathol (1999) 1.74
Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol (1994) 1.72
Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res (2000) 1.72
Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis (2000) 1.70
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70
Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol (1991) 1.70
Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol (2001) 1.68
C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med (1988) 1.67
Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ (1993) 1.65
Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol (1999) 1.64
Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells. J Infect Dis (1988) 1.63
Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J Intern Med (1995) 1.63
Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis (1992) 1.62
Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis (2013) 1.61
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) (2000) 1.61
In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother (2000) 1.61
Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis (1996) 1.60
A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev (1997) 1.57
Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol (1988) 1.56
Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect (1995) 1.54
Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J Neurol Neurosurg Psychiatry (1996) 1.51
Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis. Clin Infect Dis (1997) 1.51
Review: infectious diseases and coagulation disorders. J Infect Dis (1999) 1.50
Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run. Eur J Clin Invest (1998) 1.50
[Immunology in medical practice. XXXV. Screening of suspected immunodeficiency: diagnostic protocols for patients with opportunistic or recurrent severe infections, wasting and failure to thrive]. Ned Tijdschr Geneeskd (2000) 1.50
Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis (1995) 1.50
Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction. J Clin Microbiol (1993) 1.49
Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res (1999) 1.49
Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis (1981) 1.48
Schizophyllum commune as an emerging fungal pathogen: a review and report of two cases. Mycoses (2012) 1.48
Fas-FasL interactions modulate host defense against systemic Candida albicans infection. J Infect Dis (1999) 1.47
Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) (1997) 1.46
Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours. J Nucl Med (2000) 1.46
Chlorpromazine down-regulates tumor necrosis factor-alpha and attenuates experimental multiple organ dysfunction syndrome in mice. Crit Care Med (1998) 1.44
Treatment of suspected sporadic cases of Legionnaires' disease. Lancet (1978) 1.43
[Clinical results and costs due to improved antibiotics policies]. Ned Tijdschr Geneeskd (1999) 1.43
Genotypic characterization of sequential Candida albicans isolates from fluconazole-treated neutropenic patients. J Infect Dis (1994) 1.43
Scintigraphic detection of bone and joint infections with indium-111-labeled nonspecific polyclonal human immunoglobulin G. J Nucl Med (1990) 1.42
Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis (1998) 1.42
Biodistribution and kinetics of radiolabeled proteins in rats with focal infection. J Nucl Med (1992) 1.41
Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci. Eur J Nucl Med (1995) 1.41
Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis (2000) 1.39
[A very serious course of psittacosis in pregnancy]. Ned Tijdschr Geneeskd (1998) 1.39
[Optimizing the antibiotics policy in the Netherlands. IV. SWAB- guidelines for antimicrobial therapy of adults with sepsis in hospitals. Foundation Antibiotics Policy Work Group]. Ned Tijdschr Geneeskd (1999) 1.39
[Invasive aspergillosis: epidemiology, diagnosis and therapy]. Ned Tijdschr Geneeskd (1994) 1.39
Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis (1990) 1.39
[Health Council Report'Preoperative evaluation: reconsideration of basic assumptions]. Ned Tijdschr Geneeskd (1997) 1.38
Retracted [Clinical reasoning and decision making in practice. A man with pneumonia and ill smelling watery sputum: the truth revealed after 80 years]. Ned Tijdschr Geneeskd (2003) 1.38
Somatic hypotheses of war syndromes. Eur J Clin Invest (2000) 1.38
[Residents not-in-training and hospital physicians: the pariahs in the hospital?]. Ned Tijdschr Geneeskd (1997) 1.38
[Somatic and psychological symptoms in soldiers after military clashes and peace-keeping missions]. Ned Tijdschr Geneeskd (1999) 1.38
[Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)]. Ned Tijdschr Geneeskd (1998) 1.38
Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis (1994) 1.37
Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood (1995) 1.37
Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol (1995) 1.36